The University of Chicago Header Logo

Connection

Olufunmilayo Olopade to Cisplatin

Back to Details
This is a "connection" page, showing publications Olufunmilayo Olopade has written about Cisplatin.
Olufunmilayo Olopade
Connection Strength
0.032
Cisplatin
  1. Phase I trial of erlotinib-based multimodality therapy for inoperable stage III non-small cell lung cancer. J Thorac Oncol. 2008 Sep; 3(9):1003-11.
    View in: PubMed
    Score: 0.017
  2. An exploratory analysis of HER-2 amplification and overexpression in advanced endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 2008 Jan; 108(1):3-9.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.